Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard S&P 500 ETF (VOO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard S&P 500 ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Vanguard S&P 500 ETF trades at $691.96. Which is the better fit depends on your goals.
| ARKG | VOO | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $698.29 |
52-Week Low | $23.09 | $571.45 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
VOO, the Vanguard S&P 500 ETF, trades at $693.83, up 0.45% today, with a bullish technical signal from moving averages and overall market sentiment. The ETF nears record highs amid strong AI-driven earnings optimism, with a dividend of $1.96 scheduled for June 2026. Key resistance lies at $699, while support holds at $681.
Outlook remains positive due to S&P 500 earnings strength and institutional inflows, but risks include Fed policy uncertainty and stretched valuations. Investors benefit from broad market exposure, though volatility may rise with economic shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard S&P 500 ETF
VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →
